Yahoo
NSE - Delayed Quote INR

Laurus Labs Limited (LAURUSLABS.NS)

2,348.00 -57.50 (-2.39%)
At close: 3:29:29 PM GMT+5:30
Dividend
LAURUSLABS.NS announced a cash dividend of INR 1.00 with an ex-date of Nov. 6, 2026

Key Executives

Amounts are as of December 31, 2026 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
Name Title Pay Exercised Year Born
Dr. Satyanarayana Chava M.Sc., Ph.D.
CEO & Whole Time Director 248M -- 1961
Mr. Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A.
CFO & Whole-Time Director 66M -- 1965
Mr. Gogireddy Venkateswar Reddy
VP of Legal, Compliance Officer & Company Secretary -- -- --
Dr. Chunduru Venkata Lakshmana Rao M.Sc., Ph.D.
Executive Director of Quality & Executive Director 45.6M -- 1962
Mr. Krishna Chaitanya Chava
Executive Director 22M -- 1990
Ms. Soumya Chava
Executive Director - Generics & Executive Director 13.5M -- 1986
Mr. B. V. R. K. Suryadevara Srinivasa Rao
President of Manufacturing and Operations -- -- 1968
Mr. Vivek Kumar
Senior General Manager of Investor Relations -- -- --
Mr. Narasimha Rao Chava
Executive Vice President of Human Resources -- -- 1968
Mr. Srinivasa Rao Suryadevara B.Sc, M.Sc.
Executive Vice President of Manufacturing -- -- 1963

Laurus Labs Limited

Jubilee Hills
Plot No. 103 Road No.1
Hyderabad, 500033
India
91 40 6659 4333 https://www.lauruslabs.com
Sector: 
Healthcare
Full Time Employees: 
7,059

Description

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal-origin-free recombinant proteins and cell-culture media supplements and research and development services, including drug substance development, drug product development, and biologics development. In addition, the company offers non-human ingredients; rare disease therapeutics; and finished dosages. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.

Corporate Governance

Laurus Labs Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 6, 2026 at 12:00 AM UTC

Ex-Dividend Date

January 22, 2027 at 10:00 AM UTC

Laurus Labs Limited Earnings Date

Recent Events

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: